Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

DaVita and Myriad establish protein biomarker discovery collaboration

June 19, 2013

No Comments

PsychoGenics and Sunovion Pharmaceuticals expand CNS partnership

June 19, 2013

No Comments

Canadian acceptance of MycoTool for release testing of Roche product

June 18, 2013

No Comments

Shionogi to collaborate with Irish universities

June 18, 2013

No Comments

Novel, non-chemical, approach towards regenerative medical therapy

June 17, 2013

No Comments

Sea Lane grants Takeda access to ConCIRT libraries for use in drug discovery

June 14, 2013

No Comments

Biosortia collaborates to discover natural products for infectious disease

June 14, 2013

No Comments

UCB to collaborate with Crelux and 4SC Discovery in neurology

June 12, 2013

No Comments

FDA grants orphan drug status to TH-302, SL-401 and Pheburane

June 12, 2013

No Comments

Zebrafish model/computational screening to accelerate drug discovery

June 11, 2013

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

DaVita and Myriad establish protein biomarker discovery collaboration

PsychoGenics and Sunovion Pharmaceuticals expand CNS partnership

Canadian acceptance of MycoTool for release testing of Roche product

Shionogi to collaborate with Irish universities

Novel, non-chemical, approach towards regenerative medical therapy

Sea Lane grants Takeda access to ConCIRT libraries for use in drug discovery

Biosortia collaborates to discover natural products for infectious disease

UCB to collaborate with Crelux and 4SC Discovery in neurology

FDA grants orphan drug status to TH-302, SL-401 and Pheburane

Zebrafish model/computational screening to accelerate drug discovery

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS